U.S. Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Highlights: Navigating Supply Chain Challenges and Strong International Growth
Despite supply chain hurdles, Prestige Consumer Healthcare Inc (PBH) reports robust free cash flow and international expansion, with a focus on strategic improvements and market resilience. Nov 08, 2024
GuruFocus News Drug Manufacturers
Cannabist Company Holdings Inc (CBSTF) Q3 2024 Earnings Call Highlights: Navigating Divestitures and Targeting Profitability
Despite revenue decline, Cannabist Company Holdings Inc (CBSTF) focuses on strategic divestitures and aims for a 20% adjusted EBITDA margin by 2025. Nov 08, 2024
GuruFocus News Drug Manufacturers
Elanco Animal Health Inc (ELAN) Q3 2024 Earnings Call Highlights: Strategic Innovations and Debt Reduction Amid Revenue Challenges
Elanco Animal Health Inc (ELAN) focuses on new product launches and significant debt paydown to drive future growth despite current revenue declines. Nov 08, 2024
GuruFocus News Drug Manufacturers
Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and Preparing for Vafseo Launch
Despite a decline in revenue, Akebia Therapeutics Inc (AKBA) focuses on strategic initiatives for Vafseo's market entry and maintaining financial stability. Nov 08, 2024
GuruFocus News Drug Manufacturers
Esperion Therapeutics Inc (ESPR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions
Esperion Therapeutics Inc (ESPR) reports significant revenue growth and strategic advancements, despite facing competitive and operational challenges. Nov 08, 2024